L. Barber

发表

Diabetes mellitus and experimental vein graft structure and function.

M. Davies, P. Hagen, C. Carson, 1994, Journal of vascular surgery.

Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts.

M. Davies, P. Hagen, E. Svendsen, 1998, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Reduction of lipid peroxidation with intraoperative superoxide dismutase treatment decreases intimal hyperplasia in experimental vein grafts.

M. Davies, P. Hagen, H. Safi, 1999, The Journal of surgical research.

Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809.

M. Davies, P. Hagen, E. Svendsen, 1998, Surgery.

Combination Therapy of Cholesterol Reduction and l-Arginine Supplementation Controls Accelerated Vein Graft Atheroma

M. Davies, P. Hagen, T. Huynh, 1999, Annals of vascular surgery.

Early Morphology of Accelerated Vein Graft Atheroma in Experimental Vein Grafts

M. Davies, P. Hagen, T. Huynh, 1999, Annals of vascular surgery.

Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.

M. Davies, P. Hagen, E. Svendsen, 1997, The Journal of surgical research.

The influence of the combined presence of diabetes mellitus and hypercholesterolaemia on the function and morphology of experimental vein grafts.

M. Davies, P. Hagen, H. Dalen, 1995, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Postoperative reduction of high serum cholesterol concentrations and experimental vein bypass grafts. Effect on the development of intimal hyperplasia and abnormal vasomotor function.

M. Davies, P. Hagen, H. Dalen, 1994, The Journal of thoracic and cardiovascular surgery.

Local inhibition of tyrosine kinase activity markedly attenuates the development of intimal hyperplasia in experimental vein grafts.

M. Davies, P. Hagen, E. Svendsen, 1998, The Journal of surgical research.

Control of the structural and functional consequences of vein graft intimal hyperplasia with a 21-aminosteroid--U74389G.

M. Davies, P. Hagen, H. Dalen, 1994, European journal of vascular surgery.

Ramipril and Experimental Vein Graft Intimal Hyperplasia

M. Davies, P. Hagen, E. Svendsen, 1995, Angiology.

The temporal sequence of G-protein expression in intimal hyperplasia.

M. Davies, P. Hagen, T. Gettys, 1996, The Journal of surgical research.

Hypercholesterolemia and experimental vein grafts: accelerated development of intimal hyperplasia and an increase in abnormal vasomotor function.

M. Davies, P. Hagen, R. McCann, 1993, The Journal of surgical research.

Characterisation of angiotensin II receptor mediated responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809.

M. Davies, P. Hagen, H. Dalen, 1996, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Locally Applied Antisense Oligonucleotide to Proliferating Cell Nuclear Antigen Inhibits Intimal Thickening in Experimental Vein Grafts

M. Davies, P. Hagen, E. Svendsen, 1998, Annals of vascular surgery.

Control of accelerated vein graft atheroma with the nitric oxide precursor: L-arginine.

M. Davies, P. Hagen, H. Dalen, 1995, The Journal of surgical research.

Reduction of experimental vein graft intimal hyperplasia by ketanserin.

M. Davies, P. Hagen, L. Schwartz, 1993, The Journal of surgical research.

Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.

M. Davies, P. Hagen, H. Dalen, 1996, The Journal of surgical research.